EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, OPORF: Open Orphan Plc.

02 Jan 2026
LAST:

0.0861

CHANGE:
 0.05		OPEN:
0.0861		HIGH:
0.0861		ASK:
0.0000		VOLUME:
200
CHG(%):
17.24		PREV:
0.2900		LOW:
0.0861		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Open Orphan Plc.
About:hVIVO plc operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including assay development, cell based assays, molecular, immunology, virology, clinical field trail logistics, and biomarker analysis services. It has a portfolio of human challenge study models for conditions, such as RSV, influenza, COVID-19, hMPV, HRV, asthma, malaria, and COPD. In addition, the company offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, it provides pre­clinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company offers services to big pharma and biotech organizations. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:40 Bank Street, London, United Kingdom, E14 5NR
Website:https://www.hvivo.com
FIGI:BBG00SXJD1S3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:12.00 
Forward P/E:12.14 
Price to Sales:3.03 
Price to Book:2.80 
DivYield:0.01 
Div/Share:0.00 
Revenue:54.47M 
EBITDA:8.24M 
Shares:687.22M 
Market Cap:59.17M